Symptoms and Testing information for PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test

Symptoms and Testing information for PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test

Symptoms of PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1

Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1) is a rare genetic disorder caused by mutations in the PIGN gene. This condition is characterized by a wide range of symptoms that can vary significantly among affected individuals. However, some common features have been identified, which include congenital anomalies, muscle hypotonia (reduced muscle tone), and seizures. Understanding the symptoms of this syndrome is crucial for early diagnosis and management.

Key Symptoms and Features

The symptoms of MCAHS1 are diverse, and they can be present from birth or develop within the first few months of life. Some of the key features include:

  • Congenital Anomalies: These can include structural brain abnormalities, cleft lip and palate, congenital heart defects, and abnormalities in other organs.
  • Muscle Hypotonia: Affected individuals often exhibit significantly reduced muscle tone, making it difficult for them to maintain posture and perform physical activities.
  • Seizures: Seizures are a common symptom and can vary in severity and frequency among individuals with MCAHS1.
  • Developmental Delay: Children with MCAHS1 may experience delays in reaching developmental milestones such as sitting, standing, and speaking.
  • Intellectual Disability: Varying degrees of intellectual disability are common, affecting the ability to learn and process information.
  • Visual and Hearing Impairments: Some individuals may have vision and hearing problems, further complicating the developmental challenges.
  • Facial Dysmorphisms: Distinctive facial features may include a high forehead, wide nasal bridge, and low-set ears.

Importance of Genetic Testing

Genetic testing for the PIGN gene is vital for diagnosing MCAHS1. It allows for the confirmation of the diagnosis, which is crucial for the management and treatment of the condition. Early diagnosis through genetic testing can also provide families with valuable information regarding the prognosis and the likelihood of the syndrome occurring in future pregnancies.

PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test

The genetic test for MCAHS1 involves analyzing the DNA to identify mutations in the PIGN gene that are responsible for the syndrome. This test is offered by DNA Labs UAE, a leading genetic testing facility dedicated to providing accurate and comprehensive genetic diagnostics. The cost of the test is 4400 AED, which reflects the intricate process of genetic analysis and the invaluable insights it provides for affected families.

Conclusion

MCAHS1 is a complex syndrome with a wide range of symptoms that can significantly impact the quality of life of affected individuals and their families. Understanding the symptoms and undergoing genetic testing for the PIGN gene mutation are critical steps in managing the condition effectively. For more information about the genetic test and to schedule a consultation, please visit DNA Labs UAE.

Leave a Reply
Home Sample Collection

Sample Collection at Home

100% Accuarte results

Each sample is tested twice

Reports from Accrediated Labs

Get Tested from certified labs

100% Secure Checkout

PayPal / MasterCard / Visa